glp 1 osa GLP-1 vs. CPAP: What Works Best for Sleep Apnea? Tirzepatide in Obesity-Related Obstructive Sleep

The results of this first extended study were impressive, with the 15 mg dose of tirzepatide producing a 2.4% reduction in HbA1c (compared to 1.1% for dulaglutide) and 11.3 kg weight loss (compared to 4.8 kg for dulaglutide)

Patients who stop GLP-1 therapy often regain weight within months, but steady access removes the financial friction that causes treatment gaps

While GLP-1 medications can initially reduce energy levels as your body adjusts, incorporating movement is crucial for preserving muscle mass

Through phage display screening, the peptide sequence CKGGRAKDC was identified as a ligand for an inhibitory protein that is highly expressed in the endothelial cells of WAT [78]

The postmarketing experience section now includes reports of dysgeusia (altered sense of taste)